Foscavir and Etoposide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Foscavir (foscarnet sodium) and Etoposide (etoposide). Common drug interactions include systemic candida among females and agranulocytosis among males.

The phase IV clinical study analyzes what interactions people have when they take Foscavir and Etoposide. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Foscavir?

Foscavir has active ingredients of foscarnet sodium. eHealthMe is studying from 1,631 Foscavir users. Check the latest studies of Foscavir.

What is Etoposide?

Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.

On Jul, 11, 2026

27 people who take Foscavir and Etoposide together, and have interactions are studied.

Foscavir and Etoposide drug interactions.

What are the common drug interactions of Foscavir and Etoposide, by gender? *:

female:

Systemic candida (whole body fungal infection)
Liver disorder (liver diseases)
Angioimmunoblastic t-cell lymphoma (mature t-cell cancer of the blood or lymph vessel)
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Cytomegalovirus infection
Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
Pancreatitis acute (sudden inflammation of pancreas)
Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
Septic shock (shock due to blood infection)
Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)

male:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Disease progression
Sepsis (a severe blood infection that can lead to organ failure and death)
Sinusitis (inflammation of sinus)
Encephalitis cytomegalovirus (inflammation of the brain due to cytomegalovirus)
Anaemia (lack of blood)
Engraftment syndrome (inflammatory condition during neutrophil recovery after hematopoietic stem cell transplantation)
Haematuria (presence of blood in urine)
Histiocytosis haematophagic
Infection

What are the common drug interactions of Foscavir and Etoposide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
Cardiac failure
Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
Cytomegalovirus infection
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Haematuria (presence of blood in urine)
Histiocytosis haematophagic
Hypokalaemia (low potassium)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Pyrexia (fever)

10-19:

Abdominal pain
Acute lymphocytic leukaemia (cancer of the white blood cells)
Arthralgia (joint pain)
Bacterial infection
Blood creatinine increased
Cough
Cytomegalovirus infection
Diarrhoea
Epistaxis (bleed from the nose)
Epstein-barr virus infection

20-29:

n/a

30-39:

n/a

40-49:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Cytomegalovirus viraemia (cytomegalo virus in blood stream)
Disease progression
Encephalitis cytomegalovirus (inflammation of the brain due to cytomegalovirus)
Neutropenia (an abnormally low number of neutrophils)
Systemic candida (whole body fungal infection)
Anaemia (lack of blood)
Cystitis haemorrhagic (blood in the urine and painful voiding)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Histiocytosis haematophagic

50-59:

Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)
Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)

60+:

Angioimmunoblastic t-cell lymphoma (mature t-cell cancer of the blood or lymph vessel)
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
Liver disorder (liver diseases)
Pancreatitis acute (sudden inflammation of pancreas)
Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
Septic shock (shock due to blood infection)
Systemic candida (whole body fungal infection)
Epstein-barr virus infection

What are the existing conditions these people have? *

B Precursor Type Acute Leukaemia (lymphoid cancer): 7 people, 25.93%
Haemorrhage (bleeding): 7 people, 25.93%
Infection: 6 people, 22.22%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 18.52%
Angioimmunoblastic T-Cell Lymphoma (mature t-cell cancer of the blood or lymph vessel): 5 people, 18.52%
Interstitial Lung Disease: 4 people, 14.81%
Bone Marrow Conditioning Regimen: 4 people, 14.81%
Septic Shock (shock due to blood infection): 3 people, 11.11%
Cytomegalovirus Infection: 3 people, 11.11%
Adverse Event: 3 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Foscavir and Etoposide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously